Richard Bagley

Präsident bei Samus Therapeutics, Inc.

80 Jahre

Health Technology

Energy Minerals

Consumer Services

Aktive Positionen von Richard Bagley

Unternehmen	Position	Beginn	Ende
Samus Therapeutics, Inc. Samus Therapeutics, Inc. BiotechnologyHealth Technology Samus Therapeutics, Inc. operates as an biopharmaceutical company. It develops novel therapeutics targeting the epichaperome to enhance degradation of aberrant proteins which drive the pathology of diseases such as neurodegenerative and cancer. The company is headquartered in Topsfield, MA.	Präsident	01.11.2016	-

Unternehmen	Position	Beginn	Ende
ALAUNOS THERAPEUTICS, INC.	Direktor/Vorstandsmitglied	23.06.2011	16.07.2012
	Geschäftsführer	01.09.2005	16.07.2012
	Finanzdirektor/CFO	01.09.2005	09.05.2012
	Präsident	01.09.2005	16.07.2012
	Treasurer	01.09.2005	09.07.2012
ZIOPHARM, Inc.	Geschäftsführer	01.07.2004	01.09.2005
ZIOPHARM, Inc.	Präsident	01.07.2004	01.09.2005
TWIN BUTTE ENERGY LTD.	Präsident	01.01.1998	01.05.2003
ProScript, Inc. ProScript, Inc. Pharmaceuticals: MajorHealth Technology Part of Takeda Pharmaceutical Co., Ltd., ProScript, Inc. is a company that develops anti-cancer treatments. The company is based in Cambridge, MA. The company was founded by Tom Maniatis. ProScript was acquired by LeukoSite, Inc., part of Takeda Pharmaceutical Co., Ltd. from December 22, 1999 on July 20, 1999 for $3.35 million.	Vorsitzender	01.01.1994	01.01.1998
	Präsident	01.01.1994	01.01.1998
ImmuLogic Pharmaceutical Corp. ImmuLogic Pharmaceutical Corp. Pharmaceuticals: MajorHealth Technology ImmuLogic Pharmaceutical Corporation is a biopharmaceutical company. The company focuses on the research and clinical development of products to treat allergies, autoimmune diseases, and vaccines for the management of drugs of abuse. It was founded on March 26, 1987 and is headquartered in Woburn, MN.	Präsident	01.01.1990	01.01.1994
E. R. Squibb & Sons LLC	Präsident	01.01.1988	01.01.1989
Smithkline & French Laboratories US, Inc.	Corporate Officer/Principal	01.01.1968	01.01.1985

Harvard Graduate School of Education

Graduate Degree

International

Vereinigte Staaten	9
Kanada	2

Operativ

Sektoral

Besetzte Positionen

Aktive

Inaktive

Börsennotierte Unternehmen

Private Unternehmen

Börsennotierte Unternehmen	2
TWIN BUTTE ENERGY LTD.	Energy Minerals
ALAUNOS THERAPEUTICS, INC.	Health Technology

Private Unternehmen	6
ImmuLogic Pharmaceutical Corp. ImmuLogic Pharmaceutical Corp. Pharmaceuticals: MajorHealth Technology ImmuLogic Pharmaceutical Corporation is a biopharmaceutical company. The company focuses on the research and clinical development of products to treat allergies, autoimmune diseases, and vaccines for the management of drugs of abuse. It was founded on March 26, 1987 and is headquartered in Woburn, MN.	Health Technology
ZIOPHARM, Inc.	Health Technology
ProScript, Inc. ProScript, Inc. Pharmaceuticals: MajorHealth Technology Part of Takeda Pharmaceutical Co., Ltd., ProScript, Inc. is a company that develops anti-cancer treatments. The company is based in Cambridge, MA. The company was founded by Tom Maniatis. ProScript was acquired by LeukoSite, Inc., part of Takeda Pharmaceutical Co., Ltd. from December 22, 1999 on July 20, 1999 for $3.35 million.	Health Technology
Smithkline & French Laboratories US, Inc.
E. R. Squibb & Sons LLC
Samus Therapeutics, Inc. Samus Therapeutics, Inc. BiotechnologyHealth Technology Samus Therapeutics, Inc. operates as an biopharmaceutical company. It develops novel therapeutics targeting the epichaperome to enhance degradation of aberrant proteins which drive the pathology of diseases such as neurodegenerative and cancer. The company is headquartered in Topsfield, MA.	Health Technology